Bacil Pharma informs about quarterly statement on investor complaints

19 Oct 2016 Evaluate

Bacil Pharma has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended September 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Bacil Pharma Share Price

4.85 0.06 (1.25%)
May 23, 18:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 921.45
Cipla 970.55
Dr. Reddy's Lab 4274.25
Aurobindo Pharma 558.85
Lupin 618.40
View more..